谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

NISCAHN: A Phase II, Multicenter Nonrandomized Trial Aiming at Evaluating Nivolumab (N) in Two Cohorts of Patients (pts) with Recurrent/metastatic (R/M) Salivary Gland Carcinoma of the Head and Neck (SGCHN), on Behalf of the Unicancer Head & Neck Group.

Jerome Fayette,Caroline Even,Laurence Digue,Lionnel Geoffrois,Frederic Rolland,Didier Cupissol,Joel Guigay,Christophe Le Tourneau,Anne-Francoise Dillies,Sylvie Zanetta,Laurence Bozec Lemoal,Christian Borel,Aurelie Guyennon,Sophie Couchon-Thaunat,Valerie Costes,Isabelle Jallut,Jessy Delaye,Audrey Lardy-Cleaud,Sylvie Chabaud

Journal of clinical oncology（2019）

引用 36|浏览89
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要